CRSP - CRISPR/Vertex gene editing therapy approved in U.S. for beta-thalassemia
2024-01-16 15:06:13 ET
More on CRISPR, Vertex Pharma, etc.
- Impact Of Gene Therapies And Casgevy On Crispr AG And The Industry
- CRISPR Therapeutics AG (CRSP) 42nd Annual J.P. Morgan Healthcare Conference (Transcript)
- Vertex Pharmaceuticals Is One Of Our Favorite Biotech Ideas
- First RSV shots, groundbreaking gene therapy among 2024 drugs to watch
- Vertex announces Saudi Arabian approval of Casgevy for sickle cell, TDT
For further details see:
CRISPR/Vertex gene editing therapy approved in U.S. for beta-thalassemia